Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence

Lower extremity artery disease (LEAD) affects millions of elderly patients and is associated with elevated cardiovascular morbidity and mortality. Risk factor modification, including the therapy of dyslipidaemia, is mandatory to reduce cardiovascular event rates and to improve survival rates. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Linda, Engelbertz, Christiane, Reinecke, Holger, Freisinger, Eva, Malyar, Nasser M., Meyborg, Matthias, Brix, Tobias J., Varghese, Julian, Gebauer, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692475/
https://www.ncbi.nlm.nih.gov/pubmed/36431315
http://dx.doi.org/10.3390/jcm11226838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692475/
https://www.ncbi.nlm.nih.gov/pubmed/36431315
http://dx.doi.org/10.3390/jcm11226838

Ejemplares similares